COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Platelets - 3rd Edition - ISBN: 9780123878373, 9780123878380


3rd Edition

Editor: Alan Michelson
eBook ISBN: 9780123878380
Hardcover ISBN: 9780123878373
Imprint: Academic Press
Published Date: 10th December 2012
Page Count: 1400
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Platelets - winner of a 2013 Highly Commended BMA Medical Book Award for Internal Medicine - is the definitive current source of state-of-the-art knowledge about platelets and covers the entire field of platelet biology, pathophysiology, and clinical medicine. Recently there has been a rapid expansion of knowledge in both basic biology and the clinical approach to platelet-related diseases including thrombosis and hemorrhage. Novel platelet function tests, drugs, blood bank storage methods, and gene therapies have been incorporated into patient care or are in development. This book draws all this information into a single, comprehensive and authoritative resource.

Key Features

  • Highly Commended BMA Medical Book Award 2013: Internal Medicine
  • Comprehensive and definitive source of knowledge about platelets for clinicians, pathologists and scientists
  • Integrates the entire field of platelet biology, pathophysiology, and clinical medicine
  • Full color reference comprising 64 chapters, 1400 pages, and 16,000 references
  • Contributions from 126 world leaders in their fields
  • New chapters on topics such as the regulation of platelet life span, platelet microRNAs, GPVI and CLEC-2, monitoring of antiplatelet therapy, novel antiplatelet therapy, and making platelets ex vivo


Hematologists, cardiologists, blood bankers, stroke physicians, pathologists, researchers in thrombosis and hemostasis, and students and fellows working in these fields

Table of Contents

Foreword: A Brief History of Ideas About Platelets in Health and Disease

I The Role of Platelets in Human Hemostasis, Platelet Transfusion, and the Bleeding Time

II Immune Thrombocytopenia

III Alloantigens, Single Nucleotide Polymorphisms, and Alloimmune Thrombocytopenias

IV Platelet Physiology, Assays of Platelet “Adhesiveness”, ADP, Platelet Aggregation, Myocardial Infarction, and P2Y12 Antagonists

V Aspirin, Arachidonic Acid, Prostaglandins, Gpiib-iiia, Nitric Oxide, Endothelial Gpiib-iiia, and Angiogenesis

VI Clot Retraction, Glanzmann Thrombasthenia, GPIIb-IIIa Receptor, and GPIIb-IIIa Antagonists

VII Bernard-Soulier Syndrome, the Gpib-IX-V Complex, von Willebrand Factor, Shear, ADAMTS-13, and Thrombotic Thrombocytopenic Purpura

VIII Thrombin-induced Platelet Activation

IX Platelets and Metastases

X Reflections on the Past and Thoughts About the Future

Part I: Platelet Biology

Chapter 1. The Evolution of Mammalian Platelets

I Introduction

II Invertebrates

III Nonmammalian Vertebrates

IV Comparative Hemostasis

V A Comparison of Human Platelets and Limulus Amebocytes

VI The Evolution of Hemostasis and Blood Coagulation

VII Megakaryocytes and Mammals

VIII Conclusions



Chapter 2. Megakaryocyte Development and Platelet Formation

I Introduction

II Megakaryocyte Development

III Platelet Formation

IV Regulation of Megakaryocyte Development and Platelet Formation

V Murine Model Systems and Human Diseases as Tools to Study Platelet Biogenesis


Chapter 3. The Regulation of Platelet Life Span

I Introduction

II History

III Methods for the Measurement of Platelet Life Span

IV An Introduction to Apoptosis

V An Apoptotic Pathway Regulates Platelet Survival and Life Span

VI Distinct Pathways Promote Platelet Procoagulant Function

VII Clearance Mechanisms of Platelets and Clearance Signals

VIII Future Questions



Chapter 4. Platelet Genomics

I Introduction

II Human Genomics

III Platelet Genomic Association Studies: Phenotype Issues

IV Genome-Wide Association Studies (GWAS)

V Cardiovascular Disease Genomic (DNA) Association Studies

VI Platelet Genomic Studies with Intermediate (Platelet QTL) Outcomes

VII Platelet-Megakaryocyte Transcriptome Association Studies

VIII Mechanistic Insights from Platelet Genomic Studies

IX Platelet Pharmacogenetics

X GWAS Perspectives

XI The Future


Chapter 5. Platelet microRNAs

I The microRNA Pathway of Human Cells

II Platelets

III The microRNA Pathway of Platelets

IV Use of Platelet microRNAs as Biomarkers

V Therapeutic Applications

VI Conclusion and Perspectives



Chapter 6. The Platelet Proteome

I Introduction

II The Platelet Proteome

III Factors that Influence the Make-Up of the Platelet Proteome

IV Evaluating the Platelet Proteome

V Summary and Future Directions


Chapter 7. Platelet Structure

I Introduction

II Peripheral Zone

III The Sol-Gel Zone

IV Organelle Zone

V Platelet Membrane Systems


Chapter 8. The Platelet Cytoskeleton

I Introduction

II The Structure of the Resting Platelet

III The Cytoskeleton of the Resting Platelet

IV The Structure of the Activated Platelet

V Signals Activating Actin Assembly

VI Membrane Dynamics and Actin Filament Turnover in Platelets

VII Platelet Contraction

VIII Diseases of the Platelet Cytoskeleton


Chapter 9. Platelet Receptors

I Introduction

II Integrins

III Leucine-Rich Repeat (LRR) Family

IV Seven-Transmembrane Receptors

V Immunoglobulin Superfamily

VI C-Type Lectin Receptor Family

VII Tetraspanins

VIII Glycosyl Phosphatidylinositol (GPI)-Anchored Proteins

IX Glycosaminoglycan-Carrying Receptors

X Tyrosine Kinase Receptors

XI Miscellaneous Platelet Membrane Glycoproteins



Chapter 10. The GPIb-IX-V Complex

I Introduction/Structure

II Function

III Signaling

IV Conclusions


Chapter 11. GPVI and CLEC-2

I Introduction to Platelet ITAM and HemITAM Receptors



IV Conclusions


Chapter 12. Integrin αIIbβ3

I Introduction

II αIIbβ3 as an Integrin and a Platelet Protein

III Structure of αIIbβ3

IV “Inside-Out” Signaling and αIIbβ3 Activation

V Conclusions


Chapter 13. Protease-Activated Receptors

I Introduction

II Structure and Mechanism of Activation of PARS

III A Dual Protease-Activated Receptor System for Human Platelet Activation

IV Pharmacology of PAR Ligands and Antagonists in Platelets

V PAR1 and PAR4 Signaling in Platelets

VI Role of Secreted ADP in Thrombin-Induced Platelet Aggregation

VII PAR-Activated Prothrombinase Activity and Thrombin Generation


Chapter 14. The Platelet P2 Receptors

I P2 Receptors

II Roles of Adenine Nucleotides in Platelet Function


IV P2Y12

V P2X1

VI Interplay Between the Platelet P2 Receptors

VII Desensitization of the Platelet P2 Receptors

VIII Conclusions


Chapter 15. PECAM-1

I Introduction

II PECAM-1 Genomic Organization and Protein Domain Structure

III Expression and Adhesive Properties of the Extracellular Domain

IV Phosphorylation, Cytoskeletal Association, and Protein Interactions of the PECAM-1 Cytoplasmic Domain

V PECAM-1 as a Bidirectional Regulator of Platelet Reactivity and Thrombosis

VI Allelic and Soluble Isoforms of PECAM-1 and their Association with Cardiovascular Disease

VII Conclusions


Chapter 16. Interactions Between Platelets, Leukocytes and the Endothelium

I Mediators

II Functional Consequences

III Pathophysiologic Roles

IV Concluding Remarks



Chapter 17. Inhibition of Platelet Function by the Endothelium

I Introduction

II Nitric Oxide

III Prostacyclin

IV CD39 (NTPDase-1)

V Summary



Chapter 18. Platelet Secretion

I Introduction: Platelet Granules

II Formation of Platelet Granules

III Platelet Granule Content

IV Mechanisms of Platelet Granule Secretion

V Function of Platelet Granule Secretion

VI Platelet Granule Disorders

VII Conclusions



Chapter 19. Signal Transduction During Platelet Plug Formation

I Overview

II Early Events of Platelet Activation via G-Protein-Coupled Receptors

III An Agonist-Centric View of Platelet Activation

IV Contact-Dependent and Contact-Facilitated Events that Reinforce Platelet Activation

V Regulators of Platelet Activation: Obtaining an Optimal Response to Injury

VI Concluding Thoughts


Chapter 20. Platelet Thrombus Formation in Flowing Blood

I Introduction

II Initial Events in Thrombus Formation under Flow

III Thrombus Propagation under Flow

IV Conclusions


Chapter 21. Interactions Between Platelets and the Coagulation System

I Overview of the Role of Platelets in Hemostasis

II Enzyme Complex Formation Regulates the Coagulant Response

III Model Systems Defining the Role of Platelets in Tissue FACTOR-INITIATED Thrombin Generation

IV Intrinsic Platelet Molecules Involved in the Coagulant Response

V Coagulation Reactions Supported by the Activated Platelet Surface

VI Positive and Negative Effectors of Platelet Coagulant Activity

VII Summary



Chapter 22. Platelet-Derived Microparticles

I Introduction

II Microparticle Structure

III Detection of Microparticles

IV Formation and Clearance of Platelet Microparticles

V Microparticle Function

VI Clinical Disorders Associated with Microparticles

VII Future Developments


Chapter 23. The Role of Platelets in Fibrinolysis

I Introduction

II Key Mechanisms and Components of Fibrinolysis

III Inhibitors of Fibrinolysis

IV Platelet-Associated Fibrinolytic Activity

V Integrin αIIbβ3 Interactions

VI Platelet-Mediated Effects on Fibrin Structure

VII Plasmin-Mediated Platelet Activation

VIII Platelet Disorders and Fibrinolysis

IX Net Effects



Chapter 24. The Role of Platelets in Angiogenesis

I The Role of Platelets in Angiogenesis

II Platelets and Angiogenesis in Tissue Regeneration and Wound Healing

III The Effects of Platelets on Tumor Dynamics


Chapter 25. Platelet Function in the Newborn

I Introduction

II Platelet Number and Size

III Platelet Production

IV Platelet Structure

V Measurements of Platelet Function

VI Platelet Activation During Delivery

VII Platelet Adhesion

VIII Platelet Signal Transduction

IX Platelet Secretion

X Platelet Procoagulant Activity

XI Effects of Drugs on Fetal and Neonatal Platelet Function

XII Effects of Maternal Disease on Fetal and Neonatal Platelet Function

XIII Conclusions


Part II: Tests of Platelet Function

Chapter 26. Clinical Tests of Platelet Function

I Introduction

II Early Tests of Platelet Number and Function

III Overview of Currently Available Platelet Function Tests

IV Use of Platelet Function Testing in the Clinical Setting

V Summary and the Future of Platelet Function Testing


Chapter 27. Platelet Counting

I Introduction

II Manual Platelet Counting

III Automated Platelet Counting

IV Reticulated Platelets/Immature Platelet Fraction

V Conclusions


Chapter 28. Platelet Aggregation

I Overview of Methods for the Evaluation of Platelet Aggregation

II Preparation of Samples for Platelet Aggregation Tests

III Analytical Considerations and Potential Interferences for Aggregation Tests

IV Quantitative Endpoints of Aggregation and Release Assays

V Aggregation Interpretation in the Assessment of Bleeding Disorders

VI Quality Evaluation of Platelet Aggregation Tests


Chapter 29. Flow Cytometry

I Introduction

II Measurement of Platelet Activation

III Diagnosis of Specific Disorders

IV Monitoring of Antiplatelet Agents

V Monitoring of Thrombopoiesis

VI Blood Bank Applications

VII Platelet-Associated IgG

VIII Platelet Count

IX Other Research Applications


Chapter 30. Monitoring of Antiplatelet Therapy

I Introduction

II Rationale for Monitoring Antiplatelet Therapy

III Aspirin

IV Clopidogrel

V Role of Platelet Function Measurement in Patients Undergoing Coronary Artery Bypass Surgery

VI Monitoring Antiplatelet Therapy During Combination Therapies

VII Monitoring of Antiplatelet Therapy in the Medically Managed Acute Coronary Syndrome Patient

VIII Monitoring Antiplatelet Therapy During Clopidogrel and Proton Pump Inhibitor Therapy

IX Monitoring Antiplatelet Therapy During GPIIb-IIIa Antagonist Therapy

X Guidelines

XI Future


Chapter 31. Real Time In Vivo Imaging of Platelets During Thrombus Formation

I Introduction

II Equipment and Methods

III Data Acquisition and Analysis

IV Study of Thrombus Formation

V Conclusions


Part III: The Role of Platelets in Disease

Chapter 32. Atherothrombosis and Coronary Artery Disease

I Platelets Initiate Atherosclerosis—A Model of Platelet-Induced Disease

II Platelet Adhesion Promotes Initiation of Atherosclerosis

III Platelet Secretion and Generation of Cytokines

IV Platelets and Dendritic Cells

V Impact of Platelets on Endothelial Regeneration

VI Platelets and Thrombosis in the Course of Atherosclerosis

VII Therapeutic Implications and Management of Coronary Artery Disease

VIII Conclusions


Chapter 33. Central Nervous System Ischemia

I Introduction

II Ischemic Cerebrovascular Disease

III Platelet Activation in the Development of Focal Cerebral Ischemia

IV Hemorrhagic Transformation

V Antiplatelet Interventions in Cerebral Ischemia

VI Carotid Artery Atherothrombotic Disease

VII Cerebral Embolism from a Cardiac Source

VIII Conclusions


Chapter 34. Peripheral Vascular Disease

I Overview of Peripheral Arterial Disease

II Platelet-Vessel Wall Interactions in PAD

III Characteristics of Platelet Function in PAD

IV Platelet-Focused Therapy in PAD

V Platelets in Venous Disease

VI Conclusions


Chapter 35. Diabetes Mellitus

I Accelerated Atherothrombosis: Epidemiological and Clinical Findings

II Are Platelets the Key Player in Diabetic Atherothrombosis?

III Mechanisms Contributing to In Vivo Platelet Activation

IV Antiplatelet Therapy for the Primary and Secondary Prevention of Atherothrombotic Events

V Less-than-Expected Response to Aspirin

VI Possible Determinants of Hyporesponsiveness to Aspirin in Diabetes

VII Conclusions



Chapter 36. Inflammation

I Introduction

II Platelet Interactions with Endothelium and Leukocytes

III Platelet Signaling Receptors, Integrins, and Immunoreceptors

IV Platelet Toll-Like Receptors

V The Platelet Secretome and Other Modes of Intercellular Signaling in Inflammation and Immune Syndromes

VI The Platelet Transcriptome and New Mechanisms for Signal-Dependent Modification of the Platelet Proteome in Inflammation

VII Platelets in Innate and Adaptive Immune Responses

VIII Platelets in Inflammation: Animal Models of Disease

IX Platelets in Human Inflammatory Diseases and Syndromes

X Platelets: Protean Activities in Defense and Disease



Chapter 37. Antimicrobial Host Defense

I Introduction

II Mammalian Platelets are Multipurpose Host Defense Cells

III Early Studies were Interpreted to Suggest Platelets Promote Infection

IV Platelets Likely Play Multiple Roles in Antimicrobial Host Defense

V Platelets Contain Antimicrobial Effector Molecules that Contribute to Host Defense

VI Platelet Host Defense Polypeptides Likely Function via Multiple Mechanisms of Action

VII Platelet Host Defense Polypeptides Potentiate Conventional Antibiotics

VIII PMPs and Platelet Kinocidins Modulate Pathogen Interactions with Platelets and Endothelial Cells

IX Platelets Modulate Complement Activation

X Platelets Influence the Host Defense Roles of Lymphocytes

XI Platelets Potentiate the Antimicrobial Functions of Leukocytes

XII Platelets are Integral to Antimicrobial Host Defense In Vivo

XIII Certain Pathogens May Subvert Platelet Host Defenses

XIV Correlates of Platelet Quantity or Function and Risk of Infection

XV Future Studies

XVI Summary



Chapter 38. Tumor Growth and Metastasis

I Introduction

II The Platelet–Tumor Cell Axis

III Platelet–Tumor Cell Emboli and Ischemia

IV Platelets, Tumor Cells, and Innate Immunity

V Platelets and Angiogenesis

VI Platelet Activation and Metastasis

VII Platelet Therapies and Cancer

VIII Conclusion and Perspectives


Part IV: Disorders of Platelet Number and Function

Chapter 39. The Clinical Approach to Disorders of Platelet Number and Function

I Introduction

II Clinical History

III Physical Examination

IV Clinical Tests

V Differential Diagnosis

VI Specific Disorders


Chapter 40. Immune Thrombocytopenia (ITP)

I Introduction

II Incidence

III Etiology and Pathophysiology

IV Diagnosis and Clinical Assessment

V Management

VI Prognosis

VII Summary



Chapter 41. Drug-Induced Thrombocytopenia

I Introduction

II Drug-Induced Suppression of Platelet Production

III Drug-Induced Platelet Destruction by Nonimmune Mechanisms

IV Drug-Induced Platelet Destruction by Immune Mechanisms


Chapter 42. Heparin-Induced Thrombocytopenia

I Introduction

II Historical Aspects and Nomenclature

III Pathogenesis

IV Frequency

V Clinical Features

VI Diagnosis

VII Management


Chapter 43. Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome

I Introduction


III Shiga Toxin-associated HUS

IV Atypical HUS



Chapter 44. Thrombocytopenia in Pregnancy

I Introduction

II Specific Causes of Pregnancy-Associated Thrombocytopenia

III Summary and Conclusions


Chapter 45. Thrombocytopenia in the Newborn

I Introduction

II Fetal Megakaryocytopoiesis and Platelet Production

III Incidence of Neonatal Thrombocytopenia

IV Natural History of Neonatal Thrombocytopenias

V Conditions Leading to Clinically Significant Neonatal Thrombocytopenia

VI Diagnosis of Neonatal Thrombocytopenia

VII Platelet Transfusion for Neonatal Thrombocytopenia

VIII Future Therapeutic Options for Neonatal Thrombocytopenia

IX Summary


Chapter 46. Alloimmune Thrombocytopenia

I Introduction

II Fetal and Neonatal Alloimmune Thrombocytopenia

III Post-Transfusion Purpura

IV Passive Alloimmune Thrombocytopenia

V Unresolved Questions and Future Directions


Chapter 47. Inherited Thrombocytopenias

I Introduction

II The Microthrombocytic Thrombocytopenias

III The Normothrombocytic Thrombocytopenias

IV The Macrothrombocytic Thrombocytopenias

V An Approach to Patients with Suspected Congenital Thrombocytopenia


Chapter 48. Pseudothrombocytopenia

I Introduction

II EDTA-Dependent Pseudothrombocytopenia

III Citrate-Dependent Pseudothrombocytopenia

IV Other Anticoagulants

V Clinical Aspects

VI Pseudothrombocytopenia Agglutinins as Natural Antibodies

VII Clinical Laboratory Procedures

VIII Pseudothrombocytopenia Due to Platelet Satellitism

IX Pseudothrombocytopenia Due to Therapeutic Monoclonal Antibodies

X Conclusions


Chapter 49. Thrombocytosis and Essential Thrombocythemia

I Introduction

II Congenital Thrombocytosis

III Reactive Thrombocytosis

IV Primary Thrombocytosis and the Myeloproliferative Neoplasms

V Distinguishing Reactive Thrombocytosis from Primary Thrombocytosis

VI Essential Thrombocythemia

VII Concluding Comments


Chapter 50. Congenital Disorders of Platelet Function

I Introduction

II Classification of Congenital Disorders of Platelet Function

III Abnormalities of the Platelet Receptors for Adhesive Proteins

IV Abnormalities of the Platelet Receptors for Soluble Agonists

V Defects of Platelet Granules

VI Defects of Signal Transduction

VII Abnormalities of Membrane Phospholipids

VIII Miscellaneous Disorders of Platelet Function

IX Hereditary Defects of Adhesive Proteins, Affecting Platelet Function

X Prevalence of and Diagnostic Evaluation of Congenital Disorders of Platelet Function

XI Treatment of Congenital Platelet Function Disorders

XII Future Avenues of Research

XIII Conclusions


Chapter 51. Acquired Disorders of Platelet Function

I Introduction

II Uremia

III Myeloproliferative Diseases

IV Acute Leukemias and Myelodysplastic Syndromes

V Dysproteinemias

VI Acquired von Willebrand Disease

VII Acquired Storage Pool Disease

VIII Antiplatelet Antibodies and Platelet Dysfunction

IX Liver Disease

X Miscellaneous Conditions with Impaired Platelet Function

XI Drugs That Inhibit Platelet Function



Chapter 52. Cardiopulmonary Bypass

I Introduction

II Clinical Aspects of CPB Relevant to Platelet Pathophysiology

III Inflammation and CPB

IV Clinical Hemostatic Alterations During and After CPB

V Quantitative Platelet Abnormalities During CPB

VI Qualitative Platelet Abnormalities During CPB

VII Diagnostic and Therapeutic Issues in CPB Hemostasis


Part V: Antiplatelet Therapy

Chapter 53. Aspirin

I Historical Background

II Mechanism of Action

III Pharmacokinetics and Pharmacodynamics

IV Drug Interactions

V Inter-Individual Variability in Drug Response

VI Clinical Readouts of Platelet COX-1 Inactivation

VII Balance of Benefits and Risks

VIII Conclusions



Chapter 54. ADP Receptor Antagonists

I Introduction

II Thienopyridines

III Direct P2Y12 Antagonists

IV Conclusions


Chapter 55. αIIbβ3 (GPIIb-IIIa) Antagonists

I Introduction

II General Information and Mechanism of Action

III Landmark Clinical Trials: Percutaneous Coronary Intervention

IV Landmark Clinical Trials: Non-ST-Elevation Acute Coronary Syndromes

V Landmark Clinical Trials: ST-Elevation Myocardial Infarction

VI Relative Efficacy of GPIIb-IIIa Antagonists

VII Special Circumstances and Alternative Strategies to GPIIb-IIIa Antagonists

VIII Side Effects

IX Conclusions


Chapter 56. Dipyridamole

I Introduction

II Absorption and Metabolism

III Mechanisms of Action

IV Side Effects

V Conclusions


Chapter 57. Cilostazol

I Introduction

II Mechanism of Action

III Antiplatelet Effects

IV Antithrombotic Effects

V Other Effects

VI Clinical Results


Chapter 58. Novel Antiplatelet Therapies

I Introduction

II Platelet Biology

III Current Antiplatelet Therapies

IV Novel Antiplatelet Therapies

V Conclusions


Part VI: Therapy to Increase Platelet Numbers and/or Function

Chapter 59. Thrombopoietin Mimetics

I Introduction

II TPO Structure

III The TPO Gene and Its Regulation

IV Functions of TPO

V Physiology of TPO

VI Pathophysiology of TPO

VII Therapeutic Thrombopoietins

VIII Clinical Effects of Therapeutic Thrombopoietins: Animal Studies

IX Clinical Effects of Therapeutic Thrombopoietins: Human Studies

X Adverse Effects of Therapeutic Thrombopoietins in Humans

XI Interleukin-11 (A Non-TPO Thrombopoietic Growth Factor)


Chapter 60. Desmopressin (DDAVP)

I Introduction

II Management with Desmopressin of Mild Hemophilia A and von Willebrand Disease

III Desmopressin as a General Hemostatic Agent

IV Side Effects

V Mechanisms of Action of Desmopressin

VI Conclusions


Chapter 61. Factor VIIa

I Introduction

II Pharmacology

III rFVIIa in the Treatment of Thrombocytopenia

IV rFVIIa in the Treatment of Platelet Function Disorders

V Adverse Events

VI Mechanisms of Action

VII FVIIa Analogs in Clinical Development

VIII Conclusions



Chapter 62. Platelet Transfusion Medicine

I Introduction

II Platelet Preparation

III Platelet Storage and Storage Injury

IV Postcollection Processing

V Platelet Transfusion Therapy

VI Adverse Reactions to Platelet Transfusion

VII Thrombopoietic Growth Factors in Platelet Transfusion Therapy

VIII Conclusions


Chapter 63. Making Platelets Ex Vivo

I Introduction

II Generating Human Megakaryocytes and Platelets Ex Vivo

III Targeted Therapy via Platelets

IV Conclusions


Chapter 64. Gene Therapy for Platelet Disorders

I Introduction

II Approach to Gene Transfer for Platelet Disorders

III Advances in Retrovirus-Mediated Transduction for Platelets

IV State-of-the-Art Animal Models for Disorders Affecting Platelets

V Conclusions





No. of pages:
© Academic Press 2012
10th December 2012
Academic Press
eBook ISBN:
Hardcover ISBN:

About the Editor

Alan Michelson

Alan Michelson

Dr. Michelson is Professor of Pediatrics and Professor of Medicine at Harvard Medical School in Boston, Massachusetts, U.S.A. He is also the Director of the Center for Platelet Research Studies ( and the Director of the Thrombosis and Anticoagulation Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. After receiving his medical degree with honors from the University of Adelaide, Australia, Dr. Michelson continued his medical and research training on a Fulbright Scholarship at Boston Children’s Hospital, Brigham and Women’s Hospital, and Harvard Medical School. In 2019 he received the International Society on Thrombosis and Haemostasis (ISTH) Esteemed Career Award. Dr. Michelson has been an invited participant in numerous National Institutes of Health working groups, international workshops and consensus conferences. He is the co-organizer and co-chair of the biennial International Platelets Symposium. Dr. Michelson is a past Chairman of the Platelet Physiology Scientific Subcommittee of the ISTH. He has published more than 450 original research articles, original research abstracts, and invited reviews – nearly all on the topic of platelets. Dr. Michelson has been the principal investigator on more than 100 research grants. He has been an invited speaker at over 200 major medical conferences worldwide. Dr. Michelson is an inventor on two awarded and three provisional U.S. patents.

Affiliations and Expertise

Professor of Pediatrics and Professor of Medicine, Harvard Medical School, Boston, MA, USA; Director, Center for Platelet Research Studies and Director, Thrombosis and Anticoagulation Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA


BMA Medical Book Award 2013: Internal Medicine - Highly Commended, British Medical Association


"Platelets fills an important niche on the bookshelf of any academic hematologist. The user-friendly online access to the figures contained in the textbook will be especially useful for teaching purposes…this encyclopedia of the platelet contains critical information for physicians, educators, students, and research scientists.", 2014

"Comprehensive and definitive, this third-edition reference integrates platelet biology, pathophysiology, and clinical medicine. Sixty-four chapters address biology, function, disease, disorders of platelet number or function, antiplatelet therapy, and therapy to increase numbers and/or function." --Reference and Research Book News 2013

"I've been reading various chapters for the past few days and have been marveling at the sheer depth and breadth. No other textbook or other reference source is comparable…You must have this book if your practice or interest even superficially touches on platelets.", 2013

"Platelets is the definitive current source of state- of-the-art knowledge about platelets and covers the entire field of platelet biology, pathophysiology, and clinical medicine."

"One might well question the value of a doorstopper-sized textbook in this era of instant Internet access to all variety of even the most arcane information. A notable exception, however, is the third edition of Michelson’s Platelets. The surprising complexity of these anucleate cells and their diverse and ever enlarging roles in physiology and disease has attracted a large cadre of interdisciplinary researchers focused on various aspects of these roles. Having at ready hand a readable, authoritative, comprehensive and beautifully illustrated and cross-referenced volume makes for easy access to important information required by these researchers – both established senior investigators and their students." --Thomas P Stossel, MD, American Cancer Society Professor of Medicine Harvard Medical School Director, Translational Medicine Unit and center for Medical Innovation Senior Physician, Hematology Division Brigham & Women's Hospital, Boston, MA, USA

Reviews of the SECOND EDITION
"...the book is a clearly written, concise, and comprehensive discussion of platelets and their disorders that will be useful to anyone whose professional activity involves these important little cells." --Journal of the American Medical Association

"This is a fantastic resource for anyone who treats patients with platelets disorders or is engaged in platelet or megakaryocyte-based research." --BRITISH JOURNAL OF HAEMATOLOGY

"This is the second edition of a comprehensive book on everything you could ever possibly want to know about platelets...The purpose is to provide a comprehensive, definitive, and authoritative book on platelets. These are worthy objectives, well met in this updated edition...This book would interest anyone wanting to learn about platelets: physicians at all stages of training or practice, clinical laboratory scientists at any stage of training or practice, and basic scientists interested in learning about clinical aspects of platelets...This is the book I'll use whenever I have to answer any type of platelet question. If you field platelet questions, you should get this book, too." --Valerie L. Ng, PhD, MD, Alameda County Medical Center/Highland Hospital, FOR DOODY'S (4 Stars)

Ratings and Reviews